Dame Davies
Director/Board Member presso UCB
Patrimonio netto: 2 539 $ in data 31/03/2024
Profilo
Dame Kay Davies is the founder of Summit Therapeutics Ltd.
(founded in 2003).
Dr. Davies is also the founder of Oxstem Ltd.
Dr. Davies's current job(s) include being an Independent Director at UCB SA since 2014, a Senior Independent Non-Executive Director at Oxford Biomedica Plc since 2021, and a Director at Genome Research Ltd.Dr. Davies's former job(s) include being the Deputy Chairman-Governors Board at The Wellcome Trust Ltd.
from 2008 to 2017, a Senior Independent Non-Executive Director at The Biotech Growth Trust Plc from 2012 to 2021, a Non-Executive Director at Genomics England Ltd., and the Head of Physiology, Anatomy & Genetics at the University of Oxford.
Dr. Davies's education history includes an undergraduate degree from the University of Oxford.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
OXFORD BIOMEDICA PLC
0.00% | 26/09/2023 | 1 000 ( 0.00% ) | 2 539 $ | 31/03/2024 |
Posizioni attive di Dame Davies
| Società | Posizione | Inizio |
|---|---|---|
| UCB | Director/Board Member | 01/01/2014 |
| OXFORD BIOMEDICA PLC | Director/Board Member | 01/03/2021 |
Genome Research Ltd.
 Genome Research Ltd. Miscellaneous Commercial ServicesCommercial Services Part of The Wellcome Trust Ltd., Genome Research Ltd. is a world-leading genomics research institute founded in 1992. The private company is based in Cambridge, UK. Genome Research delivers therapeutic, diagnostic, and production benefits in areas such as cancer, immunology, public health, and personalized treatment. The British company tackle some of the most difficult challenges in genomic research, demanding science at scale and a visionary and creative approach to research that pushes the boundaries of our understanding in ever new and exciting ways. The company's work helps improve human health and understand life on a molecular level. | Director/Board Member | 08/12/2017 |
Oxstem Ltd.
 Oxstem Ltd. BiotechnologyHealth Technology Oxstem Ltd. develops cell programming therapies. The company is headquartered in Oxford, the United Kingdom. | Founder | - |
Precedenti posizioni note di Dame Davies
| Società | Posizione | Fine |
|---|---|---|
| THE BIOTECH GROWTH TRUST PLC | Director/Board Member | 14/07/2021 |
The Wellcome Trust Ltd.
 The Wellcome Trust Ltd. Investment Trusts/Mutual FundsMiscellaneous The Wellcome Trust Ltd. engages welfare and charitable services. It supports the discovery of vaccines and drug-resistant infections, diversity and inclusion, open research, government investment in research, data sharing in public health emergencies, and strengthening ecosystems. The company was founded by Henry Wellcome in 1936 and is headquartered in London, UK. | Director/Board Member | 01/01/2017 |
Genomics England Ltd.
 Genomics England Ltd. Miscellaneous Commercial ServicesCommercial Services Genomics England Ltd. runs and delivers 100,000 genomes project. Its flagship project sequences 100,000 genomes from NHS patients with a rare disease and their families, and patients with cancer. The company was founded by Jeremy Hunt on July 5, 2013 and is headquartered in London, the United Kingdom. | Director/Board Member | - |
Summit Therapeutics Ltd.
 Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Founder | - |
| University of Oxford | Corporate Officer/Principal | - |
Formazione di Dame Davies
| University of Oxford | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| UCB | Health Technology |
| OXFORD BIOMEDICA PLC | Health Technology |
| Aziende private | 6 |
|---|---|
The Wellcome Trust Ltd.
The Wellcome Trust Ltd. Investment Trusts/Mutual FundsMiscellaneous The Wellcome Trust Ltd. engages welfare and charitable services. It supports the discovery of vaccines and drug-resistant infections, diversity and inclusion, open research, government investment in research, data sharing in public health emergencies, and strengthening ecosystems. The company was founded by Henry Wellcome in 1936 and is headquartered in London, UK. | Miscellaneous |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
The Biotech Growth Trust Plc
 The Biotech Growth Trust Plc Investment Trusts/Mutual FundsMiscellaneous The Biotech Growth Trust Plc is a closed-end investment trust. Its objective is to seek capital through investment in the worldwide biotechnology industry principally by investing in emerging biotechnology companies. The company was founded on May 20, 1997 by Christopher Thomas Evans and is headquartered in London, the United Kingdom. | Miscellaneous |
Genome Research Ltd.
Genome Research Ltd. Miscellaneous Commercial ServicesCommercial Services Part of The Wellcome Trust Ltd., Genome Research Ltd. is a world-leading genomics research institute founded in 1992. The private company is based in Cambridge, UK. Genome Research delivers therapeutic, diagnostic, and production benefits in areas such as cancer, immunology, public health, and personalized treatment. The British company tackle some of the most difficult challenges in genomic research, demanding science at scale and a visionary and creative approach to research that pushes the boundaries of our understanding in ever new and exciting ways. The company's work helps improve human health and understand life on a molecular level. | Commercial Services |
Genomics England Ltd.
Genomics England Ltd. Miscellaneous Commercial ServicesCommercial Services Genomics England Ltd. runs and delivers 100,000 genomes project. Its flagship project sequences 100,000 genomes from NHS patients with a rare disease and their families, and patients with cancer. The company was founded by Jeremy Hunt on July 5, 2013 and is headquartered in London, the United Kingdom. | Commercial Services |
Oxstem Ltd.
Oxstem Ltd. BiotechnologyHealth Technology Oxstem Ltd. develops cell programming therapies. The company is headquartered in Oxford, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Dame Davies
